PRLD
Prelude Therapeutics Incorporated
$1.01
+$0.03(+2.56%)
18
Overall
--
Value
18
Tech
--
Quality
Market Cap
$65.66M
Volume
180.26K
52W Range
$0.61 - $2.56
Target Price
$3.50
Key Metrics Overview
| Market Cap | $65.66M | P/E Ratio | N/A |
| 52W High | $2.56 | 52W Low | $0.61 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 11.6% | 52W Position | 20.5% |
| Overall Score | 18 | Value Score | -- |
| Quality Score | -- | Technical Score | 18 |
Growth Analysis
| EPS Current Est | $-1.59 | EPS Next Est | $-1.36 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRLD | $1.01 | +2.6% | 180.26K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Prelude Therapeutics Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW